Objective T helper (Th) cells play a central role in the pathogenesis of ulcerative colitis (UC). The present study analyzed the changes in circulating T cells by administration of ustekinumab (UST), an interleukin-12/23p40 antibody.
Methods CD4 T cells were isolated from peripheral blood at 0 and 8 weeks after UST treatment, and we analyzed the proportion of CD4 T cells by flow cytometry. Clinical information and laboratory data were obtained at 0, 8, and 16 weeks.
Patients We evaluated 13 patients with UC who received UST for the induction of remission between July 2020 and August 2021.
Results The median partial Mayo score improved from 4 (1-7) to 0 (0-6) (p<0.001) with UST. Among serological parameters, albumin concentrations, C-reactive protein concentrations, the sedimentation rate, and leucine-rich alpha 2 glycoprotein concentrations showed significant improvement with UST. A flow cytometric analysis of circulating CD4 T cells showed that the percentage of Th17 cells was significantly decreased by UST treatment in all patients (1.85% to 0.98%, p<0.0001). Th1 cells were significantly increased by UST treatment (9.52% to 10.4%, p<0.05), but Th2 and regulatory T cells were not significantly different. The high-Th17 subgroup had a significantly better partial Mayo score than the low-Th17 subgroup at 16 weeks after UST treatment (0 vs. 1, p=0.028).
Conclusion Treatment with UST decreases circulating Th17 cells, suggesting that this change may be related to the anti-inflammatory effect of UC.
"}],"abstractLicenseFlag":"disallow"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1410017345597671040","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Imazu Noriyuki"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410017345597671041","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Torisu Takehiro"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410017345597671042","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Ihara Yutaro"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410017345597671045","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Umeno Junji"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410017345597670913","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Kawasaki Keisuke"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410017345597671044","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Fujioka Shin"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Endoscopic Diagnostics and Therapeutics, Kyushu University Hospital, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410017345597670915","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Fuyuno Yuta"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410017345597670914","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Matsuno Yuichi"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410017345597671043","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Moriyama Tomohiko"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of International Medical, Kyushu University Hospital, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410017345597670912","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Kitazono Takanari"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"09182918"},{"@type":"EISSN","@value":"13497235"}],"prism:publicationName":[{"@language":"en","@value":"Internal Medicine"},{"@language":"en","@value":"Intern. Med."}],"dc:publisher":[{"@language":"en","@value":"The Japanese Society of Internal Medicine"},{"@language":"ja","@value":"一般社団法人 日本内科学会"}],"prism:publicationDate":"2024-01-15","prism:volume":"63","prism:number":"2","prism:startingPage":"153","prism:endingPage":"158"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","url":[{"@id":"https://www.jstage.jst.go.jp/article/internalmedicine/63/2/63_1724-23/_pdf"},{"@id":"https://search.jamas.or.jp/link/ui/2025050604"}],"availableAt":"2024-01-15","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=ustekinumab","dc:title":"ustekinumab"},{"@id":"https://cir.nii.ac.jp/all?q=flow%20cytometry","dc:title":"flow cytometry"},{"@id":"https://cir.nii.ac.jp/all?q=T%20helper%20cell","dc:title":"T helper cell"},{"@id":"https://cir.nii.ac.jp/all?q=Th17","dc:title":"Th17"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360011146182844416","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Increased expression of interleukin 17 in inflammatory bowel disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360016868470843136","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Differential Pathogenic Th17 Profile in Mesenteric Lymph Nodes of Crohn's Disease and Ulcerative Colitis Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360016870297598720","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mucosal and Systemic Immune Profiles Differ During Early and Late Phases of the Disease in Patients With Active Ulcerative Colitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360016870448243840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Interleukin-23 in the Pathogenesis of Inflammatory Bowel Disease and Implications for Therapeutic Intervention"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619543904512","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574096331203328","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn’s disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118792009344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ustekinumab Improves Active Crohn’s Disease by Suppressing the T Helper 17 Pathway"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576121222077824","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ulcerative colitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861295474664448","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The influence of cytokines on the complex pathology of ulcerative colitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044090239232","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"IL-13 mRNA Tissue Content Identifies Two Subsets of Adult Ulcerative Colitis Patients With Different Clinical and Mucosa-Associated Microbiota Profiles"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419617043968","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893758580992","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effector T cell plasticity: flexibility in the face of changing circumstances"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894971107200","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Serum IL-17A in Newly Diagnosed Treatment-Naive Patients with Ulcerative Colitis Reflects Clinical Disease Severity and Predicts the Course of Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369792132480","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370665720320","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388844178330240","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Defining the human T helper 17 cell phenotype"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670318268579840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ulcerative colitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793430919936","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis"}]}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:2012344029"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.1724-23"},{"@type":"PUBMED","@value":"37197955"},{"@type":"OPENAIRE","@value":"doi_dedup___::e1ed0f72c465c0c61410582e5cd9d4dc"}]}